Belfast investor presentation
As stated on 17 February 2020, Diaceutics PLC (AIM: DXRX), the diagnostic commercialisation company, announced that it would hold a presentation for investors on Monday, 6 April 2020 in Belfast City. The presentation was to be given jointly by Diaceutics and Fusion Antibodies plc, the specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications.
The decision has been made by the management teams of both companies to postpone this event. If you would like to view the Group’s very positive final results issued earlier this week, please see the attached link: https://polaris.brighterir.com/public/diaceutics/news/rns/story/xl3ov9x.
If you have any questions, please contact the team at Walbrook PR on 0207 933 8780 or at [email protected].
